Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novartis Ag ADR
(NY:
NVS
)
97.35
+0.01 (+0.01%)
Streaming Delayed Price
Updated: 2:30 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Novartis Ag ADR
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Sex Hormones Market to See Huge Growth by 2028 : Novartis, Sanofi, AstraZeneca, Merck
August 30, 2023
Sex Hormones- Comprehensive Study by Type (Progesterone, Testosterone, Drospirenone), Application (Topical, Inhalation, Injection, Others) Players and Region - Global Market Outlook to 2027
Via
SBWire
Transdermal Drug Patches Market to See Huge Growth : Novartis, Mylan, Accrux
August 29, 2023
Stay up-to-date with Transdermal Drug Patches Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth.
Via
SBWire
Exposures
COVID-19
A Comprehensive Study Exploring Breast Cancer Drugs Market : Key Players- Sanofi, Novartis, Lilly
August 21, 2023
The Global Breast Cancer Drugs Market offers energetic visions to conclude market size, opportunities, growth pattern, and competitive surroundings. The research is derived through primary and...
Via
SBWire
COPD & Asthma Devices Market to Witness Remarkable Growth by 2029 : Pfizer, GSK, Novartis, Merck
August 17, 2023
Stay up to date with COPD & Asthma Devices Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth.
Via
SBWire
DTx Pharma Acquisition by Novartis Generates Robust Returns for Tech Coast Angels and NuFund Venture Group
August 03, 2023
IRVINE, Calif. - Aug. 3, 2023 - PRLog -- Tech Coast Angels (TCA) and NuFund Venture Group (formerly TCA-San Diego) today announced that portfolio company DTx Pharma was acquired by Swiss pharmaceutical...
Via
PRLog
Expert Opinions on Dry Eye Treatment Innovations
July 13, 2023
CRANBURY, N.J. - July 13, 2023 - PRLog -- IVIEW Therapeutics Inc. a clinical stage biotechnology company focusing on developing innovative ophthalmic therapeutics, organized a panel of dry eye experts...
Via
PRLog
Exposures
Product Safety
Addiction Treatment Market May See New Emerging Trends: Novartis, Pfizer, Sanofi
August 17, 2023
Pune, Maharashtra -- (SBWIRE) -- 08/17/2023 -- 2023-2031 Report on Global Addiction Treatment Market by Player, Region, Type, Application and Sales Channel is the latest research study released by HTF...
Via
SBWire
Essential Thrombocythemia Market Projected to Show Strong Growth : Pharmaessentia, Bristol Myers Squibb, Shire
August 14, 2023
Get an extensive Essential Thrombocythemia Market analysis of the dominant vendors, their latest products and services, and the competitive landscape of the industry.
Via
SBWire
Immuno Oncology Market May See a Big Move : AstraZeneca, Bristol Myers Squibb, F. Hoffmann-La Roche
August 09, 2023
Stay up-to-date with Immuno Oncology Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth.
Via
SBWire
Hypertrophic Cardiomyopathy Therapeutics Market Projected to Show Strong Growth : Novartis, Gilead Sciences, ADVANZ PHARMA
August 08, 2023
Stay up-to-date with Hypertrophic Cardiomyopathy Therapeutics Market research offered by AMA. Check how key trends and emerging drivers are shaping this industry growth.
Via
SBWire
Multiple Myeloma Therapy Market Projected to Show Strong Growth : Hikma Pharmaceutical, Eagle Pharmaceuticals, Janssen Biotech
August 08, 2023
Get Multiple Myeloma Therapy Market analysis, key vendors & competitive scenario of the market prepared using market research tools such as Porter’s five forces and SWOT analysis.
Via
SBWire
Blockbuster Drugs Market Projected to Show Strong Growth : Celgene, Bristol-Myers Squibb, Pfizer
August 03, 2023
Get an extensive Blockbuster Drugs Market analysis of the dominant vendors, their latest products and services, and the competitive landscape of the industry.
Via
SBWire
Topics
Intellectual Property
Exposures
Intellectual Property
7 Best Cancer Stocks to Invest in Now
July 28, 2023
The second-largest cause of death in the U.S., more than 600,000 deaths from cancer will occur in 2023. Learn about the best cancer stocks to invest in now.
Via
MarketBeat
Topics
Death
Exposures
Death
AI for Pharma and Biotech Market May Set Massive Growth by 2030
July 24, 2023
Get a view on AI for Pharma and Biotech Market sales by marketing channels. Target important market by region and tap important dynamics of this industry.
Via
SBWire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Lilly Shares Up On Versanis Deal Amid Weight-Loss Drug Gold Rush
July 24, 2023
A bid to acquire Versanis boosts Eli Lilly & Co. by 2.80% in the past week, as the competition to develop the most effective weight-loss drug intensifies.
Via
MarketBeat
Can Novartis Move to New Highs and Sustain Them?
July 19, 2023
Novartis stock is moving higher following outperformance in Q2 and increased guidance. A $15 billion share repurchase authorization is also in play.
Via
MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
Gilead Boosts Biotech Footprint With Stakes In AlloVir And Arcus
July 13, 2023
Regulatory filings show Gilead Sciences' purchase of shares in AlloVir and Arcus. Strategic investments in the biotech sector are fairly common to boost growth.
Via
MarketBeat
Topics
Retirement
Exposures
Pension
A Comprehensive Study Exploring Viral Disease Diagnosis Market : Key Players BioMerieux, Prescient Medicine Holdings, Danaher
July 12, 2023
AMA released Viral Disease Diagnosis Market research study .Check what differences transitions in customer choices may bring?
Via
SBWire
Exposures
COVID-19
Generalized Myasthenia Gravis Market expected to rise | Companies- Biocon, Cartesian Therapeutics, UCB, Momenta Pharamaceuticals, HanAll Biopharma, Roche, Alexion, Novartis, Takeda, BioMarin
June 30, 2023
Via
AB Newswire
PetVivo Sales Spryng Higher on Injectable OA Relief for Pets
June 27, 2023
Developmental biomedical device company PetVivo Holdings Inc. (NASDAQ: PETV) makes pet medical devices and therapeutics. What kind of medical devices would
Via
MarketBeat
#blackartmatters Series And Inaugural Talk By Gallerist Lewis P. Long
July 06, 2023
Famed Harlem gallery owner, Lewis P. Long, is set to lead the first talk of #BlackArtMatters, sponsored by Morristown's revered Art in the Atrium.MORRISTOWN, N.J. - July 6, 2023 - PRLog -- Famed Harlem...
Via
PRLog
Pulmonary Sarcoidosis Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), Investigates DelveInsight | Eilly Lilly, Novartis, aTyr Pharma, Inc., Kinevant Sciences GmbH
June 27, 2023
Via
AB Newswire
Malignant Pleural Effusion Pipeline and Clinical Trials Assessment 2023: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Roche Holdings AG, Bristol Myers Squibb, Novartis, Merck
June 27, 2023
Via
AB Newswire
Exposures
Product Safety
Pulmonary Sarcoidosis Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | Novartis, aTyr Pharma, SarcoMed USA, Actelion, Bellerophon, Corbus Pharma
June 27, 2023
Via
AB Newswire
Exposures
Product Safety
Multiple Sclerosis Market | Companies – Immune Response BioPharma, Clene Nanomedicine, Sanofi, Merck Healthcare KGaA, TG Therapeutics, Apimeds, Bayer HealthCare, Novartis, expected to boost the market
June 27, 2023
Via
AB Newswire
Weight Loss Drugs Market May Set Epic Growth Story : Abbott Laboratories, Teva, Novartis
June 26, 2023
Stay up-to-date with Weight Loss Drugs Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth.
Via
SBWire
Porphyria Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies|Companies – Alynylm Pharmaceuticals, Novartis Pharmaceuticals, Cycle Pharmaceuticals, Mitsubishi Tanabe Pharmaceuticals
June 26, 2023
Via
AB Newswire
Interstitial Lung Disease Pipeline Drugs Analysis Report, 2023: FDA Approvals, Clinical Trials, Therapies, by DelveInsight | Roche, Novartis, AdAlta, Bristol-Myers Squibb, aTyr Pharma, Avalyn Pharma
June 26, 2023
Via
AB Newswire
Exposures
Product Safety
Multiple Sclerosis Market expected to rise | Companies – Immune Response BioPharma, Clene Nanomedicine, Sanofi, Merck Healthcare KGaA, TG Therapeutics, Apimeds, Bayer HealthCare, Novartis, Biogen
June 26, 2023
Via
AB Newswire
Multiple myeloma Pipeline and Clinical Trials Assessment 2023: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Novartis, AbbVie, Pfizer, Alliance Foundation Trials, LLC, Celgene
June 26, 2023
Via
AB Newswire
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.